NASA To Explore How the Sun Creates Energy
NASA launches the IRIS spacecraft, short for Interface Region Imaging Spectrograph, whose mission is to answer a fundamental question of how the sun creates ...
By: NTDTV
See original here:
NASA To Explore How the Sun Creates Energy
NASA launches the IRIS spacecraft, short for Interface Region Imaging Spectrograph, whose mission is to answer a fundamental question of how the sun creates ...
By: NTDTV
See original here:
NASA #39;s Asteroid Grand Challenge
CNN talks to Jason Kessler about NASA #39;s Asteroid Grand Challenge. For more CNN videos, check out our site at http://www.cnn.com/video/
By: CNN
See the original post here:
NASA Earth Observing Fleet including Landsat 8 2013 NASA Goddard Space Flight Center
more at http://scitech.quickfound.net/ "This animation shows the orbits of NASA #39;s current (as of May 2013) fleet of Earth remote sensing observatories. The s...
By: Jeff Quitney
Read the original here:
NASA Earth Observing Fleet including Landsat 8 2013 NASA Goddard Space Flight Center - Video
[Federal Register Volume 78, Number 126 (Monday, July 1, 2013)] [Notices] [Pages 39341-39342] From the Federal Register Online via the Government Printing Office [www.gpo.gov] [FR Doc No: 2013-15677]
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice: 13-070]
NASA Advisory Council Science Committee Planetary Science Subcommittee Meeting
AGENCY: National Aeronautics and Space Administration.
ACTION: Notice of meeting.
SUMMARY: In accordance with the Federal Advisory Committee Act, as amended, the National Aeronautics and Space Administration (NASA) announces a meeting of the Planetary Science Subcommittee of the NASA Advisory Council (NAC). This Subcommittee reports to the Science Committee of the NAC. The Meeting will be held via Teleconference and WebEx for the purpose of soliciting, from the scientific community and other persons, scientific and technical information relevant to program planning.
DATES: Friday, July 19, 2013, 9:00 a.m. to 12:00 noon, local time.
ADDRESSES: This meeting will take place telephonically and by WebEx. Any interested person may call the USA toll free conference call number 800-857-7040, pass code PSS, to participate in this meeting by telephone. The WebEx link is https://nasa.webex.com/, meeting number 994 987 970, and password PSS@Jul19.
FOR FURTHER INFORMATION CONTACT: Ms. Marian Norris, Science Mission Directorate, NASA Headquarters, Washington, DC 20546, (202) 358-4452, fax (202) or mnorris@nasa.gov.
View post:
NASA Advisory Council Science Committee Planetary Science Subcommittee Meeting 19 Jul 2013
The online portal to all things NASA NASA.gov has a new look as of today (July 1), with a lightened color palette and new navigation tools.
Among other changes, NASA has added a new window on the top right to highlight live events and upcoming news.
"When we solicited feedback on what people wanted from NASA.gov, the most-popular idea (among those we could actually implement) was to make live events more prominent," Brian Dunbar, internet services manager at NASA's Office of Communications, explained in a statement. "So here is where we'll be putting links to launches, major press conferences and speeches, planetary encounters and anything else we want to draw your attention to."
The new live events box has replaced a menu of icons directing visitors to NASA's popular topics, such as space station, solar system, commercial space, and universe news. Those channels are now available under a small drop-down menu below the live events module.
The space agency also plans to integrate social media into its online features more closely.
Most noticeable among the changes is the new look and feel of the site, which has gone from a black, grey and blue color scheme to a white and blue one.
"We hope this will address some of the complaints we've had about clutter and the page being hard to navigate visually," Dunbar wrote.
The site is a popular destination for space followers, and has been honored with numerous awards. In 2012, NASA.gov won the People's Voice Award as well as the Judges' Award for best government site in the annual Webby competition.
Check out NASA's new website design on NASA.gov here.
Follow Clara Moskowitz onTwitterandGoogle+. Follow us@Spacedotcom,FacebookandGoogle+. Original article on SPACE.com.
Read the original here:
Synopsis - Jun 28, 2013
General Information
Solicitation Number: RFI-ZP13 Posted Date: Jun 28, 2013 FedBizOpps Posted Date: Jun 28, 2013 Recovery and Reinvestment Act Action: No Original Response Date: Jul 12, 2013 Current Response Date: Jul 12, 2013 Classification Code: 99 -- Miscellaneous NAICS Code: 333314
Contracting Office Address
NASA/George C. Marshall Space Flight Center, Procurement Office, Marshall Space Flight Center, AL 35812
Description
Instrument Development for In Situ Dating Instrument for Mars 2020 mission
NASA, George C Marshall Space Flight Center (MSFC) is hereby soliciting information for potential sources for the Instrument Development for In Situ Dating Instrument for Mars 2020 mission Acquisition.
Following the announcement of the Mars 2020 rover mission in November 2012, NASA MSFC is seeking information regarding development of a potential in situ dating instrument to be flown on the rover. In accordance with FAR 15.201(e), the information requested is for planning purposes only and is not intended to bind the Government. This is a Request For Information (RFI) issued for information and planning purposes. It does not constitute a Request For Proposal.
Absolute dating of planetary samples is an essential tool to establish the chronology of geological events, including crystallization history, magmatic evolution, and alteration. NASA MSFC has developed a breadboard for the Potassium (K) - Argon Laser Experiment (KArLE), whose main objective is to conduct in situ potassium-argon dating. The experimental concept measures K using laser-induced breakdown spectroscopy (LIBS), Ar using mass spectrometry, and images the sample using optical cameras. Public presentations on the KArLE concept can be found at http://planetary.msfc.nasa.gov/KArLE.html
See the article here:
NASA RFI for In Situ Dating Instrument for Mars 2020 Mission
NASA
Irene Klotz Reuters
June 29, 2013 at 1:24 PM ET
Joe Skipper / Reuters
The space shuttle Atlantis leaves the Kennedy Space Center in Cape Canaveral, Florida November 2, 2012.
CAPE CANAVERAL, Florida NASA has selected Space Florida, a state-backed economic development agency, to take over operations, maintenance and development of the space shuttle's idled landing site at the Kennedy Space Center in Florida, officials said on Friday.
Terms of the agreement, which have not yet been finalized, were not disclosed, but Space Florida has made no secret about its desire to take over facilities no longer needed by NASA to develop a multi-user commercial spaceport, somewhat akin to an airport or seaport.
The state already has a lease for one of the space shuttle's processing hangars, and an agreement with Boeing to use the refurbished facility for its planned commercial space taxi.
The so-called CST-100 is one of three spaceships under development in partnership with NASA to fly astronauts to the International Space Station, a permanently staffed, $100 billion research outpost that flies about 250 miles above Earth.
NASA ended its 30-year space shuttle program in 2011, leaving Russia's Soyuz capsules as the sole means to transport crews to the station, a service that costs the United States more than $70 million per person. NASA hopes to buy rides commercially from a U.S. company by 2017.
Read more here:
NASA picks Florida agency to take over shuttle landing strip
Its really happening.
After four years of waiting and wondering whether SUNYIT actually would get the multimillion dollar nanotechnology complex promised by state officials in 2009, ground is being broken at the site.
Not by politicians with spotless shovels, but by real workers with heavy machinery.
The $125 million Computer Chip Commercialization Center, known as the Quad C, is expected to be completed by the end of 2014, said Alain Kaloyeros, senior vice president and CEO of Albanys College of Nanoscale Science and Technology, which is partnering with SUNYIT in the venture.
The annual operating budget is expected to exceed $500 million, he said.
Residents will see new opportunities to build high-tech careers in their own backyard, he said. Business owners will find new clients and customers. And the quality of life including the arts, recreation, entertainment and shopping districts will reflect a new vibrancy that will benefit the entire community.
Officials close to the project have hedged about how many jobs there will be, but in a previous announcement, when the project was expected to be smaller, there were set to be about 900 jobs.
Quad C is being funded through a public-private sector partnership and is linked to Albanys College of Nanoscale Science and Engineering. The chips that will be researched and developed at SUNYIT will be used in everything from phones to medical devices.
Its the foundation for a lot of good things that are going to happen, said Steve DiMeo, president of Mohawk Valley EDGE economic development agency. Its going to change the dynamics of the regional economy.
Becoming a reality
Read the original post:
Precision medicine: The future of medicine?
Dr. Laurie Glimcher, dean of Weill Cornell Medical College, and Dr. Robert Langer, the Koch Institute Professor at MIT, talk to the "CBS This Morning" co-hos...
By: CBSNewsOnline
Go here to read the rest:
Bon Jovi - Bad Medicine - Live in Gdansk
Bon Jovi PGE Arena, Gdansk.
By: Jack M
See more here:
Motorcycling is the best medicine : Vlog 16
I wake up early after hardly any sleep. I am feeling a little rough. So, I jump on the bike for a dose of adrenaline to set me up for the day.
By: timcrasher
Read the original:
Cough medicine punishment
Losing a bet means a swig of cough medicine!
By: Esteban squared
Originally posted here:
Human Genome Project : Nanotech and Microchip Precision Medicine (Jun 27, 2013)
SOURCE: http://www.cbsnews.com News Articles: Computers That You Eat (or That Eat You?) http://bigthink.com/endless-innovation/computers-that-you-eat-or-that...
By: SignsofThyComing
See the article here:
Human Genome Project : Nanotech and Microchip Precision Medicine (Jun 27, 2013) - Video
What is Health? How to be Healthy, Does Modern Medicine Work? Are Meds Safe? | The Truth Talks
Friend us!! http://www.Facebook.com/psychetruth What is Health? How to be Healthy, Does Medication Work? Are Meds Safe? Wellness | The Truth Talks Psychetrut...
By: psychetruth
Go here to see the original:
Medicine // "It #39;s Not Enough" (OFFICIAL SINGLE)
"It #39;s Not Enough" is the second song that we #39;re sharing from the new Medicine LP. #39;To the Happy Few #39; sees release on August 6th, on Captured Tracks. Pre-orde...
By: CapturedTracksBK
Read this article:
Bon Jovi - Bad medicine (concierto Madrid 2013)
Concierto de Bon Jovi en el estadio Vicente Caldern, Madrid, 27/06/2013. Gira #39;Because we can #39;.
By: Alber Loren
Follow this link:
Why Chinese Medicine? Cloud Gate Acupuncture Healing Arts | Broomfield, CO
http://www.cloudgatehealingarts.com Cloud Gate Acupuncture and Healing Arts, Broomfield, CO Gretchen Belenchia, LAc, acupuncturist and herbalist at Cloud Gat...
By: CloudgateAcupuncture
Read more:
Homeopathic Medicine -- We Only Have Good Things to Say
Homeopathic Medicine -- We Only Have Good Things to Say.
By: Don McBeardon
Read more:
Homeopathic Medicine -- We Only Have Good Things to Say - Video
Ester Chemistry - in What #39;s in a Medicine
Ester Chemistry - in What #39;s in a Medicine.
By: Roger Nixon
See more here:
NASHVILLE, Tenn. & WILMINGTON, Del.--(BUSINESS WIRE)--
Sarah Cannon Research Institute (SCRI) and AstraZeneca (AZ) announced today a collaboration in the field of personalized medicine to support development of new AstraZeneca oncology compounds. Specifically, the parties will work together on molecular profiling to classify tissue based upon genetic profiles for the purpose of treating cancers and predicting response to therapy.
Through our research, we know how vital and impactful individualized treatment options are for patients battling this complex disease, said Dee Anna Smith, chief executive officer of SCRI. By partnering with AstraZeneca, we are expanding opportunities to accelerate drug development and deliver more targeted therapies to patients who urgently need them.
Under the agreement, SCRI will work with AstraZeneca to identify potential patients for clinical trials and help explore biomarkers that predict response to specific treatments. In addition, SCRIs enhanced relationship with AstraZeneca will provide clinical program development leadership, medical expertise and oversight, and operational contract research organization (CRO) trial management for early phase clinical development of multiple oncology compounds.
Building upon this unique collaboration with SCRI allows us to continue honing our capabilities to deliver high quality research in a timely and cost-effective manner, said Vice President of Early Clinical Development for AstraZeneca, Professor Andrew Hughes. Through this cutting-edge program design, we can rapidly and effectively implement clinical trials with greater access to a network of cancer patients for enrollment.
AstraZeneca is one of the initial participants in SCRIs molecular profiling program, which is part of Sarah Cannons broader personalized medicine initiative across the United States and United Kingdom. SCRI and AstraZeneca originally entered into an agreement to develop novel oncology compounds in 2010.
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies for patients. It is one of the largest clinical research programs, conducting community-based clinical trials in oncology and cardiology through affiliations with a network of more than 700 physicians in the United States and United Kingdom. Additionally, SCRI offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites. For more information, please visit us onsarahcannonresearch.com.
About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: http://www.astrazeneca.com.
See the original post here: